What is the most likely diagnosis and recommended management for a 38‑year‑old male with secondary (central) adrenal insufficiency (low cortisol, low ACTH), normal thyroid axis, mild hyperprolactinemia, elevated insulin‑like growth factor‑1, normal pituitary MRI with contrast, and concurrent dermatomyositis or lupus?

Most Likely Diagnosis and Management

The most likely diagnosis is isolated ACTH deficiency (secondary adrenal insufficiency) with concurrent autoimmune disease (dermatomyositis/lupus), and the patient requires immediate initiation of hydrocortisone replacement therapy at 15-25 mg daily in divided doses before any further workup or treatment of other conditions. 1

Diagnostic Interpretation

Secondary Adrenal Insufficiency Confirmed

• Low cortisol with low ACTH definitively establishes secondary (central) adrenal insufficiency, distinguishing this from primary adrenal failure where ACTH would be markedly elevated (>300 pg/mL). 1
• The normal pituitary MRI with contrast does not rule out isolated ACTH deficiency, as this condition characteristically presents without structural pituitary abnormalities. 2
• Isolated ACTH deficiency (IAD) is a recognized entity where ACTH secretion fails while other pituitary hormones remain intact—exactly matching this patient's presentation with normal TSH/FT4 and normal gonadal axis (implied by age and lack of symptoms). 2, 3

Elevated IGF-1: Not Acromegaly

• The elevated IGF-1 in the setting of normal pituitary MRI and absence of acromegalic features (no headaches, no visual complaints, no typical phenotypic changes) makes growth hormone excess extremely unlikely. 1
• IGF-1 can be mildly elevated in various inflammatory and autoimmune conditions, which is the more plausible explanation given his dermatomyositis/lupus diagnosis. 1

Mild Hyperprolactinemia: Likely Non-Pathologic

• Mild prolactin elevation with normal MRI is most commonly due to stress, venipuncture, or stalk effect from subtle inflammation rather than a prolactinoma. 1
• In the context of autoimmune disease (dermatomyositis/lupus), mild hyperprolactinemia can occur as a non-specific finding. 4

Autoimmune Etiology Most Likely

• The concurrent dermatomyositis/lupus strongly suggests an autoimmune mechanism for the isolated ACTH deficiency, as lymphocytic hypophysitis can selectively target corticotrophs. 2, 3
• Autoimmune hypophysitis is a recognized cause of isolated ACTH deficiency in adults and frequently coexists with other autoimmune conditions. 2

Immediate Management: Glucocorticoid Replacement

Start Hydrocortisone Immediately

• Initiate hydrocortisone 15-25 mg daily in divided doses (e.g., 10 mg at 7:00 AM, 5 mg at 12:00 PM, 2.5-5 mg at 4:00 PM) to approximate physiological cortisol rhythm. 1
• Alternative regimens include cortisone acetate 25-37.5 mg daily or prednisone 4-5 mg daily, though hydrocortisone is preferred for its shorter half-life and ability to mimic diurnal rhythm. 1

No Mineralocorticoid Needed

• Fludrocortisone is NOT required in secondary adrenal insufficiency because the renin-angiotensin-aldosterone system remains intact (aldosterone production is preserved). 1, 2
• This distinguishes management from primary adrenal insufficiency, where mineralocorticoid replacement is mandatory. 1

Critical Safety Measures

• Never delay glucocorticoid replacement while pursuing additional diagnostic testing—the diagnosis of secondary adrenal insufficiency is already confirmed by low cortisol and low ACTH. 1
• Provide the patient with a hydrocortisone 100 mg IM emergency injection kit with self-injection training for use during acute illness or inability to take oral medications. 1
• The patient must wear a medical alert bracelet indicating adrenal insufficiency to ensure emergency stress-dose administration by healthcare providers. 1

Patient Education on Stress Dosing

Illness and Stress Management

• Instruct the patient to double or triple the usual hydrocortisone dose during fever, acute illness, severe vomiting, diarrhea, or significant physical stress. 1
• For minor stress (e.g., mild upper respiratory infection), double the dose for 1-2 days. 1
• For moderate stress (e.g., influenza, gastroenteritis), triple the dose until recovery. 1

Emergency Situations

• Seek immediate medical care if unable to take oral medications due to vomiting, or if experiencing severe weakness, confusion, hypotension, or signs of impending adrenal crisis. 1
• Administer the emergency IM hydrocortisone 100 mg injection and proceed to the emergency department if oral intake is impossible. 1

Surgical Stress Dosing

• For major surgical procedures, administer hydrocortisone 100 mg IM before anesthesia, followed by 100 mg IM every 6 hours until oral intake resumes. 1
• Mandatory endocrinology consultation is required for pre-operative stress-dose planning. 1

Additional Diagnostic Workup

Confirm Isolated ACTH Deficiency

• Measure morning (8 AM) testosterone, LH, FSH, and repeat IGF-1 to definitively confirm that other pituitary axes are intact. 1, 4
• If testosterone is low with low/normal LH and FSH, this would indicate panhypopituitarism rather than isolated ACTH deficiency. 4

Investigate Autoimmune Etiology

• Check 21-hydroxylase autoantibodies to assess for concurrent autoimmune primary adrenal insufficiency (though ACTH is low, making this unlikely). 1
• Consider anti-pituitary antibodies if available, as these may be positive in autoimmune hypophysitis. 3
• Screen for other autoimmune conditions annually, including thyroid function (TSH, free T4, anti-TPO), celiac disease (tissue transglutaminase antibodies), and vitamin B12 deficiency. 1

Re-evaluate IGF-1 After Glucocorticoid Replacement

• Repeat IGF-1 measurement in 3-6 months after starting hydrocortisone, as normalization would support the hypothesis that elevation was related to inflammatory disease or stress. 1
• If IGF-1 remains persistently elevated (>2× upper limit of normal) despite normal MRI, consider oral glucose tolerance test with GH suppression to definitively rule out acromegaly, though this remains unlikely. 1

Monitor Prolactin

• Recheck prolactin in 3 months; if it normalizes, no further action is needed. 1
• Persistent elevation >50 ng/mL warrants repeat pituitary MRI to exclude a microadenoma that was initially too small to visualize. 1

Critical Pitfall to Avoid: Thyroid Hormone Initiation

Never Start Levothyroxine Before Hydrocortisone

• Although this patient currently has normal thyroid function, if hypothyroidism develops in the future, glucocorticoid replacement must be started several days before initiating thyroid hormone to prevent precipitating a potentially fatal adrenal crisis. 1, 4
• Thyroid hormone increases cortisol metabolism and can unmask or worsen adrenal insufficiency. 1, 4

Long-Term Management and Monitoring

Lifelong Replacement Therapy

• Hydrocortisone replacement is lifelong and should never be discontinued in confirmed secondary adrenal insufficiency from non-iatrogenic causes. 1
• This is a permanent condition requiring continuous treatment. 1

Annual Follow-Up

• Review the patient at least annually with assessment of well-being, weight, blood pressure, and serum electrolytes. 1
• Monitor for signs of over-replacement (weight gain, insomnia, peripheral edema, hypertension) or under-replacement (lethargy, nausea, poor appetite, weight loss). 1
• Adjust hydrocortisone dosing based on clinical symptoms rather than serum cortisol measurements, as cortisol levels are not reliable for monitoring replacement adequacy. 1

Bone Health Monitoring

• Measure bone mineral density every 3-5 years to assess for glucocorticoid-induced osteoporosis, even though physiologic replacement doses carry lower risk than pharmacologic doses. 1

Drug Interactions

• CYP3A4 inducers (phenytoin, carbamazepine, rifampin, barbiturates) increase hydrocortisone clearance and may require dose increases. 1
• CYP3A4 inhibitors (grapefruit juice, licorice) decrease hydrocortisone clearance and may necessitate dose reductions. 1
• Avoid grapefruit juice and licorice entirely to prevent unpredictable fluctuations in cortisol levels. 1

Management of Concurrent Dermatomyositis/Lupus

Coordinate with Rheumatology

• The patient's dermatomyositis/lupus will likely require immunosuppressive therapy, which may include additional corticosteroids. 1
• Coordinate closely with rheumatology to ensure that any additional corticosteroid therapy for autoimmune disease is accounted for in the overall glucocorticoid dosing strategy. 1
• If high-dose prednisone or other corticosteroids are prescribed for dermatomyositis/lupus, the physiologic hydrocortisone replacement may be temporarily unnecessary, but stress-dosing principles still apply during acute illness or surgery. 1

Hypertension Management

• The patient's hypertension should be managed with standard antihypertensive agents, avoiding medications that interfere with fludrocortisone (though he doesn't need fludrocortisone). 1
• Monitor blood pressure closely after starting hydrocortisone, as glucocorticoid replacement can occasionally affect blood pressure control. 1

Summary of Diagnosis

This 38-year-old male has isolated ACTH deficiency (secondary adrenal insufficiency) most likely due to autoimmune lymphocytic hypophysitis, given the concurrent dermatomyositis/lupus. The elevated IGF-1 and mild hyperprolactinemia are likely non-pathologic findings related to inflammation or stress, not indicative of pituitary adenomas given the normal MRI. Immediate initiation of hydrocortisone replacement with comprehensive patient education on stress dosing and emergency management is mandatory to prevent life-threatening adrenal crisis. 1, 2, 3